Results 161 to 170 of about 213,380 (339)

Radiogenomics: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang, Qingpei Lai, Jin Cao, Jerry Chi Fung Ching, Xinzhi Teng, Jiang Zhang, Shara Wee Yee Lee, Ge Ren, Jing Cai   +8 more
wiley   +1 more source

Higher microRNA-221 and lower microRNA-451 expression are associated with poor prognosis in patients with thyroid papillary carcinoma

Anales del Sistema Sanitario de Navarra
Background. To analyze the relationship between serum microRNA-221 and microRNA-451 expression and the pathological features and prognosis of patients with thyroid papillary carcinoma. Methods.
Jiawei Wu, Weimin Sun, Jingyao Shen, Liping Hu   +3 more
doaj   +1 more source

Iodine and Thyroid Cancer in Goa [PDF]

, 2007
There is a low papillary to follicular ratio in iodine deficient areas. A study of malignant thyroid tumors done over a period of 4 years in Goa shows that the ratio of papillary to follicular carcinoma in Goa conforms to a iodine deficient status of the
Arora, Dr Raman, Dias, Dr Avril
core   +1 more source

Histomorphological study of malignant thyroid neoplasm in a tertiary care center and evaluation of Galectin 3 expression in papillary thyroid carcinoma

, 2020
Nithin Diwagar K., M Sridevi, S. Chitra
openalex   +1 more source

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Cell, 2014
N. Agrawal, Rehan Akbani, B. A. Aksoy, Adrian Ally, H. Arachchi, S. Asa, J. Auman, Miruna Balasundaram, S. Balu, S. Baylin, M. Behera, Brady Bernard, R. Beroukhim, J. Bishop, Aaron D. Black, T. Bodenheimer, L. Boice, Moiz Bootwalla, Jay Bowen, R. Bowlby, C. Bristow, Robin Brookens, Denise Brooks, Robert Bryant, Elizabeth Buda, Y. Butterfield, T. Carling, R. Carlsen, S. Carter, S. Carty, T. Chan, Amy Y. Chen, A. Cherniack, Dorothy Cheung, L. Chin, Juok Cho, Andy Chu, E. Chuah, K. Cibulskis, G. Ciriello, A. Clarke, G. Clayman, L. Cope, J. Copland, K. Covington, Ludmila V. Danilova, Tanja Davidsen, John A. Demchok, D. Dicara, Noreen Dhalla, R. Dhir, Sheliann S. Dookran, Gideon Dresdner, Jonathan V. Eldridge, G. Eley, A. El-Naggar, S. Eng, J. Fagin, T. Fennell, R. Ferris, Sheila A Fisher, S. Frazer, J. Frick, S. Gabriel, I. Ganly, Jianjiong Gao, L. Garraway, J. Gastier-Foster, G. Getz, Nils Gehlenborg, R. Ghossein, R. Gibbs, T. Giordano, Karen Gómez-Hernández, J. Grimsby, Benjamin E. Gross, R. Guin, Angela Hadjipanayis, H. Harper, D. Hayes, David I Heiman, J. Herman, K. Hoadley, Matan Hofree, R. Holt, A. Hoyle, F. Huang, Meijuan Huang, C. Hutter, T. Ideker, L. Iype, A. Jacobsen, S. Jefferys, Corbin D. Jones, Steven J. M. Jones, K. Kasaian, E. Kebebew, F. Khuri, Jaegil Kim, R. Kramer, R. Kreisberg, R. Kucherlapati, D. Kwiatkowski, M. Ladanyi, Phillip H. Lai, P. Laird, E. Lander, M. Lawrence, Darlene Lee, E. Lee, Semin Lee, William Lee, K. Leraas, T. Lichtenberg, Lee T Lichtenstein, Pei Lin, Shiyun Ling, Jinze Liu, Wenbin Liu, Yingchun Liu, V. Livolsi, Yiling Lu, Yussanne Ma, Harshad S. Mahadeshwar, M. Marra, Michael Mayo, D. McFadden, S. Meng, M. Meyerson, P. Mieczkowski, Michael B. Miller, G. Mills, Richard A. Moore, Lisle E. Mose, A. Mungall, Bradley A. Murray, Y. Nikiforov, M. Noble, A. Ojesina, T. Owonikoko, B. Ozenberger, A. Pantazi, Michael G Parfenov, P. Park, J. Parker, Evan O. Paull, C. Pedamallu, C. Perou, J. Prins, A. Protopopov, S. Ramalingam, N. Ramirez, Ricardo Ramirez, Benjamin J. Raphael, W. Rathmell, X. Ren, Sheila M. Reynolds, Esther Rheinbay, M. Ringel, M. Rivera, J. Roach, A. G. Robertson, Mara W Rosenberg, M. Rosenthal, S. Sadeghi, G. Saksena, C. Sander, Netty G Santoso, J. Schein, N. Schultz, S. Schumacher, R. Seethala, J. Seidman, Y. Şenbabaoğlu, S. Seth, S. Sharpe, K. Shaw, J. Shen, R. Shen, S. Sherman, Margi Sheth, Yan Shi, I. Shmulevich, G. Sica, J. Simons, Rileen Sinha, Payal Sipahimalani, R. Smallridge, H. Sofia, Matthew G. Soloway, Xingzhi Song, C. Sougnez, C. Stewart, P. Stojanov, Joshua M. Stuart, S. O. Sumer, Yichao Sun, B. Tabak, Angela Tam, Donghui Tan, Jiabin Tang, R. Tarnuzzer, B. Taylor, N. Thiessen, L. Thorne, V. Thorsson, R. Tuttle, C. Umbricht, D. V. Berg, Fabio Vandin, Umadevi Veluvolu, R. Verhaak, Michelle Vinco, Douglas Voet, Vonn Walter, Zhining Wang, S. Waring, P. Weinberger, Nils Weinhold, J. Weinstein, D. Weisenberger, D. Wheeler, M. Wilkerson, Jocelyn Wilson, M. Williams, D. Winer, L. Wise, Junyuan Wu, Liu Xi, A. W. Xu, Liming Yang, Lixing Yang, Travis Zack, M. Zeiger, Dong Zeng, J. Zenklusen, N. Zhao, Hailei Zhang, Jianhua Zhang, J. Zhang, Wei Zhang, E. Zmuda, L. Zou   +242 more
semanticscholar   +1 more source

Unveiling a BRAF Signature Proficient in Accurately Capturing Oncogenic Activity and Guiding Prognostic Prediction Across Multiple Cancers

MedComm, Volume 7, Issue 2, February 2026.
The BRAF25 meta‐signature effectively captures BRAF‐driven oncogenic activity. By enabling precise patient stratification with distinct mutation profiles, BRAF25 identifies BRAF‐active tumor subtypes and provides superior prognostic value compared with mutation status alone.
Kaidi Yang, Shihui Fu, Jingbing Liang, Lijuan Ding, Junhao You, Fang Li, Ye Yuan, Xiu‐Wu Bian   +7 more
wiley   +1 more source

Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells

Cancer Management and Research, 2019
Kader Ugur,1 Suleyman Aydin,2 Tuncay Kuloglu,3 Gokhan Artas,4 Mehmet Ali Kocdor,5 İbrahim Sahin,2,6 Meltem Yardim,2 İbrahim Hanefi Ozercan41Department of Endocrinology and Metabolism Disease, School of Medicine, Firat University, Elazig, Turkey ...
Ugur K, Aydin S, Kuloglu T, Artas G, Kocdor MA, Sahin İ, Yardim M, Hanifi Ozercan I   +7 more
doaj  

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

JAMA Oncology, 2016
Y. Nikiforov, R. Seethala, G. Tallini, Z. Baloch, F. Basolo, L. Thompson, J. Barletta, B. Wenig, A. Al Ghuzlan, K. Kakudo, T. Giordano, V. Alves, E. Khanafshar, S. Asa, A. El-Naggar, W. Gooding, S. Hodak, R. Lloyd, G. Maytal, O. Mete, M. Nikiforova, V. Nosé, M. Papotti, D. Poller, P. Sadow, A. Tischler, R. Tuttle, Kathryn B Wall, V. Livolsi, G. Randolph, R. Ghossein   +30 more
semanticscholar   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study

MedComm, Volume 7, Issue 2, February 2026.
Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang, Haoyu Wang, Yiwei Tong, Jin Hong, Yifei Zhu, Weili Ren, Jing Yu, Haoting Shi, Weiqi Gao, Siji Zhu, Jiayi Wu, Ou Huang, Jing Li, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, Xiaosong Chen   +17 more
wiley   +1 more source